Our Team
Reid Rubsamen
CEO of FlowPharma
The current CEO and Director of FlowPharma, graduated from the University of California, Berkeley with a major in computer science and a PhD in medicine from Stanford University. In 1989, he worked as a physician at Massachusetts General Hospital and served as the founder of Aladdin Corporation (IPO listed in 1996).
Under his leadership, Flow Pharma collaborated with multiple Chinese, European, and American companies to develop a highly accurate new antigen selection system that can identify and validate cancer cell targets within 3.5 weeks. Based on these targets, a fully personalized cancer vaccine was manufactured within a week and delivered to patients.
He did not profit from the invention of vaccines because he hoped that vaccines could save as many lives as possible. He deeply understands that the technology he has developed will help many people and create a lot of social value. He stated that he will spare no effort to promote the development of the biopharmaceutical and vaccine industries.
Focus on us
Get industry dynamics